Compounds > garenoxacin
Page last updated: 2024-09-03

garenoxacin and Chlamydia Infections

garenoxacin has been researched along with Chlamydia Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cevenini, R; Donati, M; Fortugno, MT; Laghi, E; Pollini, GM; Sparacino, M1
Baltch, AL; Bopp, LH; Carpenter, AN; Halse, TA; Ritz, WJ; Smith, RP1

Other Studies

2 other study(ies) available for garenoxacin and Chlamydia Infections

ArticleYear
Comparative in vitro activity of garenoxacin against Chlamydia spp.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Chlamydophila psittaci; Fluoroquinolones; Humans; Indoles; Macrolides; Microbial Sensitivity Tests; Quinolones; Tetracyclines

2002
In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Anti-Infective Agents; Chlamydia Infections; Chlamydophila pneumoniae; Databases, Genetic; DNA, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycoplasma; Ofloxacin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 16S

2004